Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)

About this study

Last updated on

This study is for people with:Juvenile Idiopathic Arthritis
Intervention being studied:CP-690,550, CP-690,550, CP-690,550 (drug)
Purpose:
Basic Science
A study testing how a potential treatment works.
Sponsored by:Pfizer
Number of participants:26 participants
Unique study IDNCT01513902

How to apply

Find a study site convenient for you below, then email yourself the contact details and next steps.

Choose a site

Participation requirements

Open toboth females and males
Open to people aged2 to 17 years old
This trialdoes not accept healthy volunteers

There are no locations currently recruiting for this study